
Ozempic and GLP-1 Drugs: New Frontiers in Neurodegenerative Disease Treatment
The article discusses the potential of Ozempic (semaglutide), a drug primarily used for diabetes and obesity, to treat early-stage Alzheimer's disease, highlighting upcoming clinical trial results that could signal a breakthrough in Alzheimer's treatment.









